RxDoctor Payments Data

Utkucan Acar, MD

Allergy & Immunology · East Grand Forks, MNNPI 1609397421

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Amgen at 33.3% of the total.

$1,199in general payments, 2019–2025

Across 18 payments — averaging $66.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$399
  • AstraZeneca$287
  • Biocryst US Sales Co., LLC$224
  • Sanofi$133
  • Incyte Corporation$58
  • Ionis Pharmaceuticals, Inc.$50
  • plus $48 from 2 others

What the payments were for

  • Food & beverage$1,199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,199 in reported general payments places this provider in the 65th percentile of 57 allergy & immunology providers in Minnesota.

See all allergy & immunology providers in Minnesota

Medicare billing

Part B allowed, 2024
$85,167
Medicare patients
87
Services billed
2,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$55,353
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,598
Epinephrine12$2,922
Azelastine Hcl82$2,085
Ipratropium Bromide17$714
Fluticasone Propionate45$643
Famotidine24$106

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in East Grand Forks

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →